Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Top award for discovery of resistance-busting cancer drugs
ICR scientists have won the 2013 Cancer Research UK Translational Cancer Research Prize for their pioneering work discovering how HSP90 works...
Video: Top award for discovery of resistance-busting cancer drugs
ICR scientists have won the 2013 Cancer Research UK Translational Cancer Research Prize for their pioneering work discovering how HSP90 works, and a new class of drugs which can target it.
Exceptional work of clinician scientist recognised by top award
Dr Nicola Valeri has received the 2013 AstraZeneca Student Prize Award, recognising the exceptional work of an early career cancer researcher.
Double-pronged attack could treat common children’s cancer
A dual-pronged strategy using two experimental cancer drugs together could successfully treat a childhood cancer by inhibiting tumour growth
Video: Innovative experiment gives new understanding of key cancer protein
A PhD project by an ICR student has made an important discovery about a protein involved in different types of cancer, using an innovative experimental technique for studying protein functions.
The PhD Panel
Our big annual student recruitment drive has opened here at The Institute of Cancer Research, London. We're looking for the very best science students to take on our fully funded PhD projects in fields across the span of cancer research – in biology, chemistry, physics, computer science and mathematics.
Clinical trial moves lung cancer drug closer to UK use
A recently approved lung cancer drug has moved closer to UK clinical use after ICR researchers provided the latest confirmation of its safety.
ICR imaging research part of £35m funding boost
CANCER imaging is set to get a major boost from a £35 million initiative to develop cutting edge imaging technologies for cancer research.
Gene discovery points to immune link between cancer and multiple sclerosis
A genetic risk factor for multiple sclerosis (MS) has been linked to Hodgkin lymphoma, suggesting a common mechanism could be at work in the two diseases.
NICE draft guidance recommends new prostate cancer drug
Guidance recommending ICR-developed drug enzalutamide for treating metastatic prostate cancer is welcomed as the latest in a drug development golden age.
Invading cancers secrete enzyme that hijacks healthy tissue
Cancers secrete an enzyme allowing them to hijack the surrounding healthy tissue in order to create the right conditions for their invasion and spread, new research finds.
Thalidomide therapy effective for low risk myeloma patients
Thalidomide therapy can extend the lives of myeloma patients, but it isn’t suitable for everyone with the disease, ICR researchers have found.